Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mitsubishi Tanabe Pharma Corp.

Division of Mitsubishi Chemical Holdings Corp.
www.mt-pharma.co.jp/e/

Latest From Mitsubishi Tanabe Pharma Corp.

AbbVie Buys In On Morphic’s Oral Integrin Inhibitors, To Tune Of $100m

After years of industry unsuccessfully trying to find an oral version of the successful I.V. integrin inhibitors, Morphic has a prolific platform – and AbbVie is paying $100m up front for preclinical oral integrin inhibitors for fibrosis indications, potentially including NASH.

Deals Liver & Hepatic

Innovation Ecosystem Needs More Support, BioJapan Hears

Head of industry group in Japan makes personal plea at major biotech meeting for improvements to Japan’s innovation ecosystem, as government representatives say steps are already being taken to improve collaborative research and foster bioventures.

Japan Innovation

ITF Pharma Plans October US Roll-Out Of Liquid Riluzole Formulation For ALS

Early engagement with US payers suggests openness to covering a liquid form of riluzole, because the tablet version is proven, but it's impossible to take for many ALS patients, says Italfarmaco subsidiary ITF Pharma.

Rare Diseases Approvals

Innovation Critical As Japan Pharma Faces Continued Pricing Pressures

Major Japanese pharma companies will add an estimated net $6.6bn in revenues through products launched over the 10-year period to 2027 to generate a combined total of $69.5bn, although average growth will be low, constrained mainly by pricing factors at home.

Japan Business Strategies
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register